A Single Oral Immunization with Replication-Competent Adenovirus-Vectored Vaccine Induces a Neutralizing Antibody Response in Mice against Canine Distemper Virus.
[en] Canine Distemper Virus (CDV) is a fatal and highly contagious pathogen of multiple carnivores. While injectable vaccines are very effective in protecting domestic animals, their use in the wild is unrealistic. Alternative vaccines are therefore needed. Adenovirus (AdV) vectors are popular vaccine vectors due to their capacity to elicit potent humoral and cellular immune responses against the antigens they carry. In parallel, vaccines based on live human AdV-4 and -7 have been used in U.S. army for several decades as replicative oral vaccines against respiratory infection with the same viruses. Based on these observations, the use of oral administration of replication competent AdV-vectored vaccines has emerged as a promising tool especially for wildlife vaccination. Developing this type of vaccine is not easy, however, given the high host specificity of AdVs and their very low replication in non-target species. To overcome this problem, the feasibility of this approach was tested using mouse adenovirus 1 (MAV-1) in mice as vaccine vectors. First, different vaccine vectors expressing the entire or part H or F proteins of CDV were constructed. These different strains were then used as oral vaccines in BALB/c mice and the immune response to CDV was evaluated. Only the strain expressing the full length CDV H protein generated a detectable and neutralizing immune response to CDV. Secondly, using this strain, we were able to show that although this type of vaccine is sensitive to pre-existing immunity to the vector, a second oral administration of the same vaccine is able to boost the immune response against CDV. Overall, this study demonstrates the feasibility of using replicating AdVs as oral vaccine vectors to immunize against CDV in wildlife carnivores.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Du, Xiang ; Laboratory of Immunology and Vaccinology, Faculty of Veterinary Medicine, FARAH,
Goffin, Emeline ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires (DMI) > Vaccinologie vétérinaire ; Laboratory of Immunology and Vaccinology, Faculty of Veterinary Medicine, FARAH,
Gillard, Lucie ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires (DMI) > Vaccinologie vétérinaire ; Laboratory of Immunology and Vaccinology, Faculty of Veterinary Medicine, FARAH,
Machiels, Bénédicte ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires (DMI) > Vaccinologie vétérinaire ; Laboratory of Immunology and Vaccinology, Faculty of Veterinary Medicine, FARAH
Gillet, Laurent ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires (DMI) > Vaccinologie vétérinaire ; Laboratory of Immunology and Vaccinology, Faculty of Veterinary Medicine, FARAH,
Language :
English
Title :
A Single Oral Immunization with Replication-Competent Adenovirus-Vectored Vaccine Induces a Neutralizing Antibody Response in Mice against Canine Distemper Virus.
Publication date :
23 August 2022
Journal title :
Viruses
eISSN :
1999-4915
Publisher :
Multidisciplinary Digital Publishing Institute (MDPI), Ch
Loots A.K. Mitchell E. Dalton D.L. Kotze A. Venter E.H. Advances in Canine Distemper Virus Pathogenesis Research: A Wildlife Perspective J. Gen. Virol. 2017 98 311 321 10.1099/jgv.0.000666 27902345
Ke G.M. Ho C.H. Chiang M.J. Sanno-Duanda B. Chung C.S. Lin M.Y. Shi Y.Y. Yang M.H. Tyan Y.C. Liao P.C. et al. Phylodynamic Analysis of the Canine Distemper Virus Hemagglutinin Gene BMC Vet. Res. 2015 11 164 10.1186/s12917-015-0491-9 26205391
Krakowka S. Cockerell G. Koestner A. Effects of Canine Distemper Virus Infection on Lymphoid Function in vitro and in vivo Infect. Immun. 1975 11 1069 1078 10.1128/iai.11.5.1069-1078.1975 1091560
Lempp C. Spitzbarth I. Puff C. Cana A. Kegler K. Techangamsuwan S. Baumgärtner W. Seehusen F. New Aspects of the Pathogenesis of Canine Distemper Leukoencephalitis Viruses 2014 6 2571 2601 10.3390/v6072571 24992230
Beineke A. Baumgärtner W. Wohlsein P. Baumgartner W. Wohlsein P. Cross-Species Transmission of Canine Distemper Virus-an Update One Health 2015 1 49 59 10.1016/j.onehlt.2015.09.002
Takeda M. Seki F. Yamamoto Y. Nao N. Tokiwa H. Animal Morbilliviruses and Their Cross-Species Transmission Potential Curr. Opin. Virol. 2020 41 38 45 10.1016/j.coviro.2020.03.005
Roelke-Parker M.E. Munson L. Packer C. Kock R. Cleaveland S. Carpenter M. O’Brien S.J. Pospischil A. Hofmann-Lehmann R. Lutz H. et al. A Canine Distemper Virus Epidemic in Serengeti Lions (Panthera leo) Nature 1996 379 441 445 10.1038/379441a0
Seimon T.A. Miquelle D.G. Chang T.Y. Newton A.L. Korotkova I. Ivanchuk G. Lyubchenko E. Tupikov A. Slabe E. McAloose D. Canine Distemper Virus: An Emerging Disease in Wild Endangered Amur Tigers (Panthera tigris altaica) MBio 2013 4 e00410-13 10.1128/mBio.00410-13
Feng N. Yu Y. Wang T. Wilker P. Wang J. Li Y. Sun Z. Gao Y. Xia X. Fatal Canine Distemper Virus Infection of Giant Pandas in China Sci. Rep. 2016 6 27518 10.1038/srep27518
Kennedy S. Kuiken T. Jepson P.D. Deaville R. Forsyth M. Barrett T. Van De Bildt M.W.G. Osterhaus A.D.M.E. Eybatov T. Duck C. et al. Mass Die-Off of Caspian Seals Caused by Canine Distemper Virus Emerg. Infect. Dis. 2000 6 637 639 10.3201/eid0606.000613
Qiu W. Zheng Y. Zhang S. Fan Q. Liu H. Zhang F. Wang W. Liao G. Hu R. Canine Distemper Outbreak in Rhesus Monkeys, China Emerg. Infect. Dis. 2011 17 1541 1543 10.3201/eid1708.101153
Sun Z. Li A. Ye H. Shi Y. Hu Z. Zeng L. Natural Infection with Canine Distemper Virus in Hand-Feeding Rhesus Monkeys in China Vet. Microbiol. 2010 141 374 378 10.1016/j.vetmic.2009.09.024
Sakai K. Yoshikawa T. Seki F. Fukushi S. Tahara M. Nagata N. Ami Y. Mizutani T. Kurane I. Yamaguchi R. et al. Canine Distemper Virus Associated with a Lethal Outbreak in Monkeys Can Readily Adapt to Use Human Receptors J. Virol. 2013 87 7170 7175 10.1128/JVI.03479-12
Bieringer M. Han J.W. Kendl S. Khosravi M. Plattet P. Schneider-Schaulies J. Experimental Adaptation of Wild-Type Canine Distemper Virus (CDV) to the Human Entry Receptor CD150 PLoS ONE 2013 8 e57488 10.1371/journal.pone.0057488
Di Sabatino D. Savini G. Lorusso A. Canine Distemper and Endangered Wildlife: Is It Time for Mandatory Vaccination of Dogs? Vaccine 2015 33 6519 10.1016/j.vaccine.2015.05.087
Day M.J. Horzinek M.C. Schultz R.D. Squires R.A. Vaccination Guidelines Group of the World Small Animal Veterinary Association WSAVA Guidelines for the Vaccination of Dogs and Cats J. Small Anim. Pract. 2016 57 4 8 10.1111/jsap.12431
Freuling C.M. Hampson K. Selhorst T. Schroder R. Meslin F.X. Mettenleiter T.C. Muller T. The Elimination of Fox Rabies from Europe: Determinants of Success and Lessons for the Future Philos. Trans. R. Soc. B Biol. Sci. 2013 368 20120142 10.1098/rstb.2012.0142
Müller T.F. Schröder R. Wysocki P. Mettenleiter T.C. Freuling C.M. Muller T.F. Schroder R. Wysocki P. Mettenleiter T.C. Freuling C.M. Spatio-Temporal Use of Oral Rabies Vaccines in Fox Rabies Elimination Programmes in Europe PLoS Negl. Trop. Dis. 2015 9 e0003953 10.1371/journal.pntd.0003953
Wimsatt J. Biggins D. Innes K. Taylor B. Garell D. Evaluation of Oral and Subcutaneous Delivery of an Experimental Canarypox Recombinant Canine Distemper Vaccine in the Siberian Polecat (Mustela eversmanni) J. Zoo Wildl. Med. 2003 34 25 35 10.1638/1042-7260(2003)34[0025:EOOASD]2.0.CO;2
Connolly M. Thomas P. Woodroffe R. Raphael B.L. Comparison of Oral and Intramuscular Recombinant Canine Distemper Vaccination in African Wild Dogs (Lycaon pictus) J. Zoo Wildl. Med. 2013 44 882 888 10.1638/2012-0232R2.1
Goffin E. Javaux J. Destexhe E. Pretto C.D. Spindler K.R. Machiels B. Gillet L. Oral Vaccination with Replication-Competent Adenovirus in Mice Reveals Dissemination of the Viral Vaccine beyond the Gastrointestinal Tract J. Virol. 2019 93 e00237-19 10.1128/JVI.00237-19
Beard C.W. Spindler K.R. Analysis of Early Region 3 Mutants of Mouse Adenovirus Type 1 J. Virol. 1996 70 5867 5874 10.1128/jvi.70.9.5867-5874.1996
Cauthen A.N. Brown C.C. Spindler K.R. In vitro and in vivo Characterization of a Mouse Adenovirus Type 1 Early Region 3 Null Mutant J. Virol. 1999 73 8640 8646 10.1128/JVI.73.10.8640-8646.1999
Tirumuru N. Pretto C.D. Castro Jorge L.A. Spindler K.R. Mouse Adenovirus Type 1 Early Region 1A Effects on the Blood-Brain Barrier mSphere 2016 1 e00079-16 10.1128/mSphere.00079-16
Orlando E.A. Imbschweiler I. Gerhauser I. Baumgärtner W. Wewetzer K. In vitro Characterization and Preferential Infection by Canine Distemper Virus of Glial Precursors with Schwann Cell Characteristics from Adult Canine Brain Neuropathol. Appl. Neurobiol. 2008 34 621 637 10.1111/j.1365-2990.2008.00958.x
Cherpillod P. Beck K. Zurbriggen A. Wittek R. Sequence Analysis and Expression of the Attachment and Fusion Proteins of Canine Distemper Virus Wild-Type Strain A75/17 J. Virol. 1999 73 2263 2269 10.1128/JVI.73.3.2263-2269.1999
Robinson M. Li B. Ge Y. Ko D. Yendluri S. Harding T. VanRoey M. Spindler K.R. Jooss K. Novel Immunocompetent Murine Tumor Model for Evaluation of Conditionally Replication-Competent (Oncolytic) Murine Adenoviral Vectors J. Virol. 2009 83 3450 3462 10.1128/JVI.02561-08 19193803
Chen X. Zaro J.L. Shen W.C. Fusion Protein Linkers: Property, Design and Functionality Adv. Drug Deliv. Rev. 2013 65 1357 1369 10.1016/j.addr.2012.09.039 23026637
Machiels B. Lete C. Guillaume A. Mast J. Stevenson P.G. Vanderplasschen A. Gillet L. Antibody Evasion by a Gammaherpesvirus O-Glycan Shield PLoS Pathog. 2011 7 e1002387 10.1371/journal.ppat.1002387 22114560
Latif M.B. Machiels B. Xiao X. Mast J. Vanderplasschen A. Gillet L. Deletion of Murid Herpesvirus 4 ORF63 Affects the Trafficking of Incoming Capsids toward the Nucleus J. Virol. 2015 90 2455 2472 10.1128/JVI.02942-15
Bett A.J. Prevec L. Graham F.L. Packaging Capacity and Stability of Human Adenovirus Type 5 Vectors J. Virol. 1993 67 5911 5921 10.1128/jvi.67.10.5911-5921.1993
Muñoz-Alía M.A. Russell S.J. Probing Morbillivirus Antisera Neutralization Using Functional Chimerism between Measles Virus and Canine Distemper Virus Envelope Glycoproteins Viruses 2019 11 688 10.3390/v11080688
Plattet P. Alves L. Herren M. Aguilar H.C. Measles Virus Fusion Protein: Structure, Function and Inhibition Viruses 2016 8 112 10.3390/v8040112
Plotkin S.A. Correlates of Protection Induced by Vaccination Am. Soc. Microbiol. 2010 17 1055 1065 10.1128/CVI.00131-10
Jensen W.A. Totten J.S. Lappin M.R. Schultz R.D. Use of Serologic Tests to Predict Resistance to Canine Distemper Virus-Induced Disease in Vaccinated Dogs J. Vet. Diagn. Investig. 2015 27 576 580 10.1177/1040638715602291
Bergmann M. Freisl M. Zablotski Y. Khan M.A.A. Speck S. Truyen U. Hartmann K. Prevalence of Neutralizing Antibodies to Canine Distemper Virus and Response to Vaccination in Client-Owned Adult Healthy Dogs Viruses 2021 13 945 10.3390/v13050945
Schultz R.D. Thiel B. Mukhtar E. Sharp P. Larson L.J. Age and Long-Term Protective Immunity in Dogs and Cats J. Comp. Pathol. 2010 142 (Suppl. 1) S102 S108 10.1016/j.jcpa.2009.10.009
Fausther-Bovendo H. Kobinger G.P. Pre-Existing Immunity against Ad Vectors: Humoral, Cellular, and Innate Response, What’s Important? Hum. Vaccines Immunother. 2014 10 2875 2884 10.4161/hv.29594
Xiang Z.Q. Gao G.P. Reyes-Sandoval A. Li Y. Wilson J.M. Ertl H.C. Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier J. Virol. 2003 77 10780 10789 10.1128/JVI.77.20.10780-10789.2003
Gurwith M. Lock M. Taylor E.M. Ishioka G. Alexander J. Mayall T. Ervin J.E. Greenberg R.N. Strout C. Treanor J.J. et al. Safety and Immunogenicity of an Oral, Replicating Adenovirus Serotype 4 Vector Vaccine for H5N1 Influenza: A Randomised, Double-Blind, Placebo-Controlled, Phase 1 Study Lancet Infect. Dis. 2013 13 238 250 10.1016/S1473-3099(12)70345-6
De Vleeschauwer A.R. Zhou X. Lefebvre D.J. Garnier A. Watier F. Pignon C. Lacour S.A. Zientara S. Bakkali-Kassimi L. De Clercq K. et al. A Canine Adenovirus Type 2 Vaccine Vector Confers Protection against Foot-and-Mouth Disease in Guinea Pigs Vaccine 2018 36 2193 2198 10.1016/j.vaccine.2018.02.074
Henderson H. Jackson F. Bean K. Panasuk B. Niezgoda M. Slate D. Li J. Dietzschold B. Mattis J. Rupprecht C.E. Oral Immunization of Raccoons and Skunks with a Canine Adenovirus Recombinant Rabies Vaccine Vaccine 2009 27 7194 7197 10.1016/j.vaccine.2009.09.030
Le L.P. Everts M. Dmitriew I.P. Davydova J.G. Yamamoto M. Curiel D.T. Fluorescently Labeled Adenovirus with PIX-EGFP for Vector Detection Mol. Imaging 2004 3 105 116 10.1162/1535350041464874
Wang F.X. Zhang S.Q. Zhu H.W. Yang Y. Sun N. Tan B. Li Z.G. Cheng S.P. Fu Z.F. Wen Y.J. Recombinant Rabies Virus Expressing the H Protein of Canine Distemper Virus Protects Dogs from the Lethal Distemper Challenge Vet. Microbiol. 2014 174 362 371 10.1016/j.vetmic.2014.10.023
Mendonça S.A. Lorincz R. Boucher P. Curiel D.T. Adenoviral Vector Vaccine Platforms in the SARS-CoV-2 Pandemic npj Vaccines 2021 6 97 10.1038/s41541-021-00356-x
Le Gars M. Sadoff J. Struyf F. Heerwegh D. Truyers C. Hendriks J. Gray G. Grinsztejn B. Goepfert P.A. Schuitemaker H. et al. Impact of Preexisting Anti–Adenovirus 26 Humoral Immunity on Immunogenicity of the Ad26.COV2.S Coronavirus Disease 2019 Vaccine J. Infect. Dis. 2022 jiac142 10.1093/infdis/jiac142